These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 1284142)

  • 1. Angiotensin-converting enzyme inhibitors and insulin sensitivity: metabolic effects in hypertension, diabetes, and heart failure.
    Donnelly R
    J Cardiovasc Pharmacol; 1992; 20 Suppl 11():S38-44. PubMed ID: 1284142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system.
    Scheen AJ
    Drugs; 2004; 64(22):2537-65. PubMed ID: 15516153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic effects of ACE inhibitors.
    Berne C
    J Intern Med Suppl; 1991; 735():119-25. PubMed ID: 2043220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible synergistic effect of ACE inhibition and calcium-channel blockade on insulin sensitivity in insulin-resistant type II diabetic hypertensive patients.
    Rett K; Jacob S; Wicklmayr M
    J Cardiovasc Pharmacol; 1994; 23 Suppl 1():S29-33. PubMed ID: 7519694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of metabolic control by angiotensin converting enzyme (ACE) inhibition.
    Henriksen EJ; Jacob S
    J Cell Physiol; 2003 Jul; 196(1):171-9. PubMed ID: 12767053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between aspirin and angiotensin-converting enzyme inhibitors: should they be used together in older adults with heart failure?
    Ahmed A
    J Am Geriatr Soc; 2002 Jul; 50(7):1293-6. PubMed ID: 12133028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ACE-inhibition on glucose metabolism.
    Ferrière M; Bringer J; Richard JL; Rodier M; Jaffiol C; Mirouze J
    Horm Metab Res Suppl; 1990; 22():65-9. PubMed ID: 2202630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of angiotensin-converting enzyme inhibition in glucose metabolism and renal injury in diabetes.
    Velasquez MT; Bhathena SJ; Striffler JS; Thibault N; Scalbert E
    Metabolism; 1998 Dec; 47(12 Suppl 1):7-11. PubMed ID: 9867063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The renin-angiotensin-aldosterone system: a pivotal role in insulin sensitivity and glycemic control.
    Perkins JM; Davis SN
    Curr Opin Endocrinol Diabetes Obes; 2008 Apr; 15(2):147-52. PubMed ID: 18316950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACE inhibitors. A safe option for hypertension and congestive heart failure.
    Amadio P; Amadio PB; Cummings DM
    Postgrad Med; 1990 Jan; 87(1):223-6, 231-2, 235-43. PubMed ID: 2404266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of antihypertensive treatment on insulin sensitivity with special reference to ACE inhibitors.
    Berne C; Pollare T; Lithell H
    Diabetes Care; 1991 Nov; 14 Suppl 4():39-47. PubMed ID: 1748056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin converting enzyme inhibitors and moderate hypertension.
    McAreavey D; Robertson JI
    Drugs; 1990 Sep; 40(3):326-45. PubMed ID: 2226219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin converting enzyme inhibition. Unique and effective therapy for hypertension and congestive heart failure.
    DiBianco R
    Postgrad Med; 1985 Oct; 78(5):229-41, 244, 247-8. PubMed ID: 2864682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety of ACE inhibitors for the treatment of hypertension and congestive heart failure.
    Frank GJ
    Cardiology; 1989; 76 Suppl 2():56-67. PubMed ID: 2670222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of angiotensin-converting enzyme inhibition in hypertension, heart failure, and vascular protection.
    Parmley WW
    Am J Med; 1998 Jul; 105(1A):27S-31S. PubMed ID: 9707265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Possible participation of angiotensin-converting enzyme and leukocyte elastase in the pathogenesis of insulin-independent diabetes mellitus].
    Dotsenko VL; Demidova TIu; Neshkova EA; Ametov AS; Iarovaia GA
    Vopr Med Khim; 1998; 44(2):203-12. PubMed ID: 9634724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanisms of insulin sensitivity improving effects of angiotensin converting enzyme inhibitor.
    Ura N; Higashiura K; Shimamoto K
    Immunopharmacology; 1999 Oct; 44(1-2):153-9. PubMed ID: 10604539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes mellitus and heart failure: epidemiology, mechanisms, and pharmacotherapy.
    Masoudi FA; Inzucchi SE
    Am J Cardiol; 2007 Feb; 99(4A):113B-132B. PubMed ID: 17307064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New angiotensin converting enzyme inhibitors. Their role in the management of hypertension.
    Laragh JH
    Am J Hypertens; 1990 Nov; 3(11):257S-265S. PubMed ID: 2261144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.